Stock listing

BIVA:ORYN Oryzon Genomics SA Acciones

Mexican listing (BIVA) of Oryzon Genomics SA · home listing BME:ORY

Follow Oryzon Genomics SA into a list and get an email when it puts out news.

Home listing price · BME:ORY

€2.43 EUR -0.07 (-2.8%)

Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, BME:ORY

Past year -31.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€2.40 – €2.51 EUROct 30, 2026
Volume
178,481 sharesOct 30, 2026
Market cap
€199.0M EURAt the close on Oct 30, 2026 · price × 81.96M shares outstanding
52-week range
€2.40 – €3.75 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€423,892 EURMedian day 121,183 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Oryzon Genomics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:ORY · Home€2.428 EUR-0.07 (-2.8%)178,481€2.49€2.506€2.404€2.498Close on Oct 30, 2026
LSE:0RDB€2.508 EUR+0.008 (+0.3%)4,491€2.526€2.53€2.508€2.50Close on Oct 27, 2026
Frankfurt:ORN€2.436 EUR-0.008 (-0.3%)—€2.436€2.436€2.436€2.444Close on Oct 30, 2026
Stuttgart:ORN€2.484 EUR+0.01 (+0.4%)—€2.478€2.518€2.472€2.474Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · BME:ORY · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.428-0.07-2.8%€2.49€2.506€2.404178,481
€2.498+0.004+0.2%€2.484€2.518€2.48482,005
€2.494-0.016-0.6%€2.512€2.534€2.48121,183
€2.51+0.01+0.4%€2.53€2.532€2.4999,097
€2.500.000.0%€2.504€2.522€2.49498,723
€2.50-0.03-1.2%€2.54€2.556€2.486123,421
€2.53-0.072-2.8%€2.592€2.596€2.53113,036
€2.602+0.022+0.9%€2.55€2.61€2.5590,954
€2.58+0.056+2.2%€2.512€2.594€2.504151,201
€2.524-0.024-0.9%€2.554€2.558€2.512106,442
€2.548-0.006-0.2%€2.524€2.58€2.522107,645
€2.554-0.018-0.7%€2.58€2.58€2.492266,940
€2.572+0.04+1.6%€2.546€2.61€2.52307,467
€2.532-0.146-5.5%€2.646€2.664€2.48619,616
€2.678+0.028+1.1%€2.674€2.69€2.65673,218
€2.65+0.02+0.8%€2.64€2.694€2.60188,889
€2.63-0.07-2.6%€2.698€2.698€2.60243,876
€2.70-0.018-0.7%€2.708€2.718€2.6859,792
€2.718+0.018+0.7%€2.69€2.738€2.672273,107
€2.70-0.032-1.2%€2.75€2.756€2.68220,508
€2.732-0.022-0.8%€2.75€2.75€2.71285,250
€2.754-0.024-0.9%€2.758€2.774€2.7181,838
€2.778+0.068+2.5%€2.71€2.78€2.71190,927
€2.71-0.04-1.5%€2.75€2.756€2.71164,753
€2.75+0.018+0.7%€2.76€2.808€2.73216,114
€2.732+0.002+0.1%€2.72€2.76€2.7291,297
€2.73-0.002-0.1%€2.76€2.76€2.69201,664
€2.732-0.064-2.3%€2.79€2.792€2.73173,197
€2.796+0.02+0.7%€2.78€2.818€2.77455,682
€2.776-0.012-0.4%€2.772€2.788€2.75238,387
€2.788-0.024-0.9%€2.828€2.828€2.7755,352
€2.812+0.01+0.4%€2.814€2.83€2.8060,078
€2.802+0.008+0.3%€2.82€2.82€2.77834,500
€2.794+0.02+0.7%€2.798€2.814€2.7689,990
€2.774-0.014-0.5%€2.82€2.82€2.76463,495
€2.788-0.008-0.3%€2.79€2.808€2.7896,764
€2.796+0.022+0.8%€2.77€2.816€2.7771,303
€2.774-0.036-1.3%€2.83€2.83€2.7788,446
€2.81+0.022+0.8%€2.82€2.838€2.80200,980
€2.788-0.006-0.2%€2.80€2.804€2.76480,395
€2.794-0.018-0.6%€2.82€2.82€2.7957,828
€2.8120.000.0%€2.78€2.848€2.7844,253
€2.812+0.02+0.7%€2.814€2.84€2.762109,055
€2.792-0.006-0.2%€2.798€2.808€2.766110,204
€2.798-0.012-0.4%€2.87€2.87€2.794171,317
€2.81-0.01-0.4%€2.83€2.878€2.75367,327
€2.82-0.02-0.7%€2.864€2.864€2.818130,044
€2.84-0.016-0.6%€2.864€2.868€2.8472,811
€2.856+0.02+0.7%€2.82€2.874€2.8274,075
€2.836-0.018-0.6%€2.878€2.878€2.812122,320
€2.854+0.066+2.4%€2.81€2.88€2.788201,092
€2.788-0.038-1.3%€2.88€2.88€2.784275,559
€2.826-0.034-1.2%€2.852€2.876€2.81250,989
€2.86-0.04-1.4%€2.898€2.91€2.86158,008
€2.90+0.014+0.5%€2.904€2.94€2.894298,263
€2.886-0.014-0.5%€2.922€2.922€2.88125,442
€2.90-0.006-0.2%€2.89€2.926€2.89141,475
€2.906+0.004+0.1%€2.902€2.912€2.892116,448
€2.9020.000.0%€2.90€2.93€2.882191,460
€2.902-0.008-0.3%€2.918€2.92€2.90111,809
€2.91-0.008-0.3%€2.938€2.944€2.91104,342
€2.918-0.012-0.4%€2.94€2.95€2.918101,710
€2.93-0.024-0.8%€2.95€2.978€2.93311,424
€2.954+0.038+1.3%€2.90€2.96€2.90311,209
€2.916+0.036+1.3%€2.926€2.926€2.874217,473
€2.88-0.004-0.1%€2.894€2.968€2.87283,537
€2.884-0.014-0.5%€2.898€2.90€2.862215,080
Ticker
BIVA:ORY/N
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BIVA
Currency
MXN

What changed lately

Latest news

Oryzon Genomics S A to participate in upcoming events in November

Oct 28, 2026

Closed €2.49 (-0.6%) on Oct 28, 2026

Oryzon Genomics S A further strengthens vafidemstat’s patent portfolio with new decisions to grant

Oct 15, 2026

Closed €2.55 (-0.7%) on Oct 15, 2026

ORYZON receives European Medicines Agency approval to initiate the HOPE-2 Phase II study of vafidemstat for the treatment of Phelan-McDermid Syndrome

Sep 29, 2026

Closed €2.71 (-1.5%) on Sep 29, 2026

ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)

Sep 28, 2026

Closed €2.75 (+0.7%) on Sep 28, 2026

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Aug 31, 2026

Closed €2.80 (-0.4%) on Aug 31, 2026

Oryzon Genomics S A reports financial results and corporate update for half year ended June 30th, 2026

Jul 27, 2026

Closed €2.95 (-1.3%) on Jul 28, 2026

ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)

Jul 8, 2026

Closed €2.92 (-1.5%) on Jul 8, 2026

ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs

Jul 1, 2026

Closed €2.83 (-8.4%) on Jul 1, 2026

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress

Jun 11, 2026

Closed €3.12 (+0.3%) on Jun 11, 2026

ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia

Jun 2, 2026

Closed €3.08 (+0.5%) on Jun 2, 2026

All Oryzon Genomics SA news

Financings

  • Shares (capital increase)

    Jul 27, 2026 · US$13.65M

    Closed: €12M raised

    Use of proceeds: To support the pipeline through the clinical catalysts expected this year and beyond

    Closed Jul 27, 2026

  • Strategic investment of newly issued Oryzon shares

    Jul 27, 2026 · US$28.44M

    Update: €25M

    Buyers: Social Impact Fund (committed, as an anchor investor, to subscribe for newly issued shares for an aggregate investment of €25 million)

    Use of proceeds: To support Oryzon's mental health programs

    Update Jul 27, 2026

Read by 6ix AI from the company's releases

Decks

Oryzon Genomics SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 171 in all · newest Oct 28, 2026 · oldest 2015
Decks
18 decks · latest March 2026

Where Oryzon Genomics SA is listed

ListingExchangeCountryCurrency
BME:ORY · Home listingMadridSpainEUR
gettex:ORNgettexGermanyEUR
LS Exchange:A2ACV2LS ExchangeGermanyEUR
LSE:0RDBLSEUnited KingdomEUR
OTC:ORYZFOTCUnited StatesUSD
Lang & Schwarz:A2ACV2Lang & SchwarzGermanyEUR
Aquis:ORYEAquisUnited KingdomEUR
BMV:ORYNBMVMexicoMXN
Tradegate:ORNTradegateGermanyEUR
Aquis:ORYEAquisUnited KingdomEUR
BIVA:ORYN · This pageBIVAMexicoMXN
Dusseldorf:ORNDusseldorfGermanyEUR
Frankfurt:ORNFrankfurtGermanyEUR
Hamburg:ORNHamburgGermanyEUR
Munich:ORNMunichGermanyEUR
Stuttgart:ORNStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Oryzon Genomics SA.